|
SMARCB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.128420E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.517360E-01 |
| Normal-vs-Stage2 |
4.576600E-01 |
| Normal-vs-Stage3 |
7.429200E-01 |
| Normal-vs-Stage4 |
8.704800E-03 |
| Stage1-vs-Stage2 |
8.855000E-01 |
| Stage1-vs-Stage3 |
6.067600E-01 |
| Stage1-vs-Stage4 |
3.998000E-02 |
| Stage2-vs-Stage3 |
7.701000E-01 |
| Stage2-vs-Stage4 |
2.616400E-02 |
| Stage3-vs-Stage4 |
8.534000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.070560E-01 |
| Normal-vs-AfricanAmerican |
3.319200E-01 |
| Normal-vs-Asian |
2.544400E-01 |
| Caucasian-vs-AfricanAmerican |
7.594200E-01 |
| Caucasian-vs-Asian |
1.050160E-01 |
| AfricanAmerican-vs-Asian |
7.718200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.843590E-01 |
| Normal-vs-Female |
1.603770E-01 |
| Male-vs-Female |
5.646400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.111400E-01 |
| Normal-vs-Extreme_Weight |
2.591400E-01 |
| Normal-vs-Obese |
4.768000E-01 |
| Normal-vs-Extreme_Obese |
7.157800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.082400E-01 |
| Normal_Weight-vs-Obese |
9.275800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.293600E-01 |
| Extreme_Weight-vs-Obese |
7.493200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.029400E-01 |
| Obese-vs-Extreme_Obese |
9.683600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.201000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.370100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.088200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.722400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.269000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.251000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.384600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.460600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.576800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.142000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.55410000000678E-05 |
| Normal-VS-Type2 PRCC |
6.917600E-03 |
| Normal-VS-KIRP CIMP |
9.501600E-02 |
| Normal-VS-Unclassified PRCC |
9.620600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.6613999609969E-09 |
| Type1 PRCC-VS-KIRP CIMP |
5.155300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.137970E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.736400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.934100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.841170E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.451200E-01 |
| Normal-vs-N1 |
2.892200E-01 |
| Normal-vs-N2 |
6.221000E-01 |
| N0-vs-N1 |
6.100600E-01 |
| N0-vs-N2 |
6.082400E-01 |
| N1-vs-N2 |
7.806400E-01 |
|
|
